MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹90 Cr | ₹44 Cr | ₹37 Cr | ₹35 Cr | ₹30 Cr |
What is the latest Total Non-Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹30 Cr |
How is Total Non-Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹90 Cr | 105.96 | |
| Mar2024 | ₹44 Cr | 19.11 | |
| Mar2023 | ₹37 Cr | 3.91 | |
| Mar2022 | ₹35 Cr | 18.10 | |
| Mar2021 | ₹30 Cr | - | |
Compare Total Non-Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,218.0 Cr | 36.3% | 25.9% | 15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 36.3% |
25.9% |
15% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses